Pharmacokinetics

Previous Page Next Page
Section Table of Contents
Site Table of Contents
 
  • Drug Absorption II Continued

    • Aqueous Diffusion

      • Aqueous diffusion of drugs is associated with large aqueous compartments such as the interstitial space and the cytosol.12,19 

        • In addition, aqueous diffusion describes drug movement across epithelial membrane tight junctions as well as endothelial cells that line blood vessels by means of aqueous pores.

          • Under some circumstances relatively large molecules (molecular weight ~25,000) may pass through these pores.

          • Aqueous diffusion is one type of passive diffusion.

            • Lipid diffusion is the other type of passive diffusion.

            • Passive diffusion represents the most common and simplest mechanism for drug absorption, depending only on a concentration gradient.15,19

            • As noted earlier, Fick's law (of diffusion) describes passive diffusion in which drug molecules move from regions of higher to lower concentration.

              • Fick's Law12

                •  Fick's Law describes passive movement molecules down its concentration gradient.

                Flux  (J) (molecules per unit time) = (C1 - C2) · (Area ·Permeability coefficient) / Thickness

                1. Where C1 is the higher concentration and C2 is the lower concentration

                2. Area = area across which diffusion occurs

                3. Permeability coefficient: drug mobility in the diffusion path

                  • For lipid diffusion, lipid: aqueous partition coefficient -- major determinant of drug mobility

                    • Partition coefficient reflects how easily the drug enters the lipid phase from the aqueous medium.

                4. Thickness: length of the diffusion path

            • Aqueous diffusion describes movement of non-protein bound drugs as drugs associated with large plasma proteins e.g. albumin are not able to penetrate most aqueous pores.

              • Drugs which carry a charge may have transport influences by local electric fields, such as the nephron's transtubular membrane potential.12

    • Lipid Diffusion12

      • The diffusion of drugs through the lipid region of the membrane bilayer represents the central limiting factor to the drug reaching its site(s) of action.

        • This conclusion is based on the numerous lipid barriers which separate body compartments.

        • The lipid: aqueous partition coefficient described previously predicts how easily a drug moves between aqueous and lipid regions.

          • Drugs that are weak acids or weak bases may either gain or lose charge depending on local pH.

            • This is an important consideration given that charged drugs are less likely to move easily through the lipid region of the membrane bilayer.12,19 

            • A charged drug associates with water molecules (hydrophilic) and movement into the lipid region is energetically unfavorable.

            • The lipid soluble form of the drug is uncharged and the aqueous soluble form is charged.

              • The ratio of these forms for a weak acid or weak base drug is described by the Henderson-Hasselbalch equation.

              • Henderson-Hasselbalch equation:  General form:  log (protonated)/(unprotonated) = pKa-pH

                • For drugs that are weak Acids: pKa = pH + log (concentration [HA] unionized)/concentration [A-]

                  • note that if [A-] = [HA] then pKa = pH + log (1) or (since log(1) = 0), pKa = pH

                • For drugs that are weak Bases: pKa = pH + log (concentration [BH+] ionized)/concentration [B]

                  • note that if [B] = [BH+] then pKa = pH + log (1) or (since log(1) = 0), pKa = pH

                1. The lower the pH relative to the pKa the greater fraction of protonated drug is found. 

                  1. Recall that the protonated form of an acid is uncharged (neutral); however, protonated form of a base will be charged.

                2. As a result, a weak acid at acid pH will be more lipid-soluble because it is uncharged and uncharged molecules move more readily through a lipid (nonpolar) environment, like the cell membrane, compared to charged molecules

                3. Similarly a weak base at alkaline pH will be more lipid-soluble because at alkaline pH a proton will dissociate from molecule leaving it uncharged and thus free to move through lipid membrane structures.

           

Previous Page Next Page

 

Go to Top of Page

 

References

  1. Maher TJ Kiel D Chapter 6 G-Protein-Coupled Receptors in Foye's Principles of Medicinal Chemistry (Roche VF Zito SW Lemke TL Williams DA, eds) 8e Wolters Kluwer 2020.

  2. Alenghat FJ Golan DE Chapter 1 Drug-Receptor Interactions in Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy (Golan DE Armstrons EJ Armstong AW, eds) 4e Wolters Kluwer 2017.

  3. von Zastrow M Chapter 2  Drug Receptors & Pharmacodynamics in Basic & Clinical Pharmacology ( Katzung BG Vanderah TW, eds) 14e McGraw Hill 2021.

  4. Flood P Shafer SL Chapter 2 Basic principles of Pharmacology in Stoelting's Pharmacology & Physiology Anesthetic Practice (Flood P Rathmell JP Urman RD, eds) 6e 2022.

  5. Manning DR Blumenthal DK Chapter 3 Pharmacodynamics:  Molecular Mechanisms of Drug Action in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Brunton LL Knollmann BC, eds) 14e McGraw-Hill 2023.

  6. Burchum JR Rosenthal LD Charles C Chapter 5 Pharmacodynamics Lehne's Pharmacology for Nursing Care 11e Elsevier 2022.

  7. Geroge Jr AL Neilson EG Chapter 309 Cell Biology and Physiology of the Kidney in Harrison's Principles of Internal Medicine (Loscalzo J Kasper DL Longo DL Fauci AS Hauser SLs Jameson JL, eds) 21e 2022.

  8. Burchum JR Rosenthal LD Charles C Chapter 4 Pharmacokinetics Lehne's Pharmacology for Nursing Care 11e Elsevier 2022.

  9. Singer SJ Nicolson GL The Fluid Mosaic Model of the Structure of Cell Membranes. Science 1972 Feb 18; 175(4023):  720-731.

  10. Watson H Biological membranes Essays Biochem (2015) 59, 43-70. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626904/pdf/bse0590043.pdf

  11. Buxton ILO Chapter 2 Pharmacokinetics: The Dynamics of Drug Absorption, Distribution, Metabolism, and Elimination in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Brunton LL Knollmann BC, eds) 14e McGraw-Hill 2023.

  12. Katzung, BG Introduction:  Chapter 1 The Nature of Drugs & Drug Development & Regulation in Basic and Clinical Pharmacology (Katzung BG Vanderah TW, eds) 15e McGraw Hill 2021.

  13. Baca QJ Golan DE Chapter 3 Pharmacokinetics  in Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy (Golan DE Armstrons EJ Armstong AW, eds) 4e Wolters Kluwer 2017.

  14. Burchum JR Rosenthal LD Charles C Chapter 4 Pharmacokinetics Lehne's Pharmacology for Nursing Care 11e Elsevier 2022.

  15. Morris ME Morse BL Chapter 4 Membrane Drug Transporters in Foye's Principles of Medicinal Chemistry (Roche VF Zito SW Lemke TL Williams DA, eds) 8e Wolters Kluwer 2020.

  16. Chegg  https://www.chegg.com/homework-help/questions-and-answers/polar-water-figure-shows-charge-distribution-water-molecule-dipole-moment-81-h-1045-h8-dis-q45173660

  17. Unwin J Jones C Are Drugs Becoming More Lipophilic Over Time? Drug Hunter November 18, 2022 https://drughunter.com/are-drugs-becoming-more-lipophilic-over-time/

  18. Bhal SK Lipophilicity Descriptors: Understanding When to Use LogP & LogD. ACD/Labs Application Note: https://www.acdlabs.com/wp-content/uploads/download/app/physchem/logp_vs_logd.pdf; ACD Labs

  19. Glagga AA Gupta V Drug Absorption StatPearls [Internet] (StatPearls Publishing 2023 Jan; https://www.statpearls.com/) https://www.ncbi.nlm.nih.gov/books/NBK557405/#_ncbi_dlg_citbx_NBK557405 (updated version : June 23, 2022)

  20. Shukle P pKa and Drug Solubility:  Absorption and Distribution - Pharmacokinetics (PK) | Lecturio May 20, 2019 https://www.youtube.com/watch?v=5MvNh7Ur1i0